Poor targeting of therapeutics leading to severe adverse effects on normal tissues is
considered one of the obstacles in cancer therapy. To help overcome this, nanoscale drug …

UK Biobank is a large-scale prospective study with deep phenotyping and genomic data. Its
open-access policy allows researchers worldwide, from academia or industry, to perform …

Cancer is defined as a large group of diseases that is associated with abnormal cell growth,
uncontrollable cell division, and may tend to impinge on other tissues of the body by different …

Nanotechnology has enabled the development of innovative therapeutics, diagnostics, and
drug delivery systems. Nanoparticles (NPs) can influence gene expression, protein …

Post-translational modifications (PTMs) generate marginally modified isoforms of native
peptides, proteins and lipoproteins thereby regulating protein functions, molecular …

Multiomics data including imaging radiomics and various types of molecular biomarkers
have been increasingly investigated for better diagnosis and therapy in the era of precision …

Abstract Manganese dioxide (MnO 2) nanoenzymes/nanozymes (MnO 2-NEs) are 1–100
nm nanomaterials that mimic catalytic, oxidative, peroxidase, and superoxide dismutase …

Multi-omics is a cutting-edge approach that combines data from different biomolecular
levels, such as DNA, RNA, proteins, metabolites, and epigenetic marks, to obtain a holistic …

Our understanding of the molecular mechanisms underlying cancer development and
evolution have evolved rapidly over recent years, and the variation from one patient to …

Mass spectrometry (MS)-based proteomics have been increasingly implemented in various
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …